Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Dairy Sci ; 106(12): 8658-8669, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37641271

RESUMO

It is possible that some of the systemic responses to subacute ruminal acidosis (SARA) may be caused by increased intestinal starch fermentation. The objective of this experiment was to evaluate the effect of abomasal infusion of up to 3 g of corn starch/kg body weight (approximately 1.6 kg of starch/d) on fecal measures of fermentation, plasma acute phase proteins, and white blood cell populations. Six ruminally cannulated cows in late lactation were randomly assigned to duplicate 3 × 3 Latin squares with 21-d periods. Cows were fed a 20.6% starch TMR twice daily and during the last 7 d of each period cows were abomasally infused with corn starch at 0 (CON), 1 (ST1), or 3 (ST3) g/kg body weight split into 2 bolus infusions, provided every 12 h. Fecal samples were collected at 0, 6, 12, and 18 h following feeding on d 21 and were analyzed for pH, VFA, lactic acid, and lipopolysaccharide (LPS). Composite fecal samples were used to estimate apparent total-tract nutrient digestibility using undigested neutral detergent fiber as an internal marker. Blood samples were collected at 0 and 6 h relative to feeding on d 14, 18, and 21 of each period. Concentrations of haptoglobin and serum amyloid A in plasma were measured in all samples, 0 h samples on d 14 and 21 were used to measure white blood cell populations, and 0 h samples from d 14, 18, and 21 were used for flow cytometric analysis of γδ T cells. Data were analyzed in SAS using models that included fixed effects of treatment and period and the random effects of cow and square. For blood measures, d 14 samples collected before the initiation of abomasal infusions were included as covariates. Time (d or h) was added as a repeated measure in variables that included multiple samples during the abomasal infusion period. A contrast was used to determine the linear effect of increasing abomasal corn starch. Abomasal corn starch linearly decreased fecal pH and linearly increased fecal total VFA and LPS, but effects were modest, with fecal pH, total VFA, and LPS changing from 6.96, 57.7 mM, and 4.14 log10 endotoxin units (EU) per gram for the CON treatment to 6.69, 64.1 mM, and 4.58 log10 EU/g for the ST3 treatment, respectively. This suggests that we did not induce hindgut acidosis. There were no effects of treatment on apparent total-tract starch digestibility or fecal starch content (mean of 96.9% and 2.2%, respectively). Treatment did not affect serum acute phase proteins or most circulating white blood cells, but the proportion of circulating γδ T cells tended to linearly decrease from 6.69% for CON to 4.61% for ST3. Contrary to our hypothesis, increased hindgut starch fermentation did not induce an inflammatory response in this study.


Assuntos
Acidose , Doenças dos Bovinos , Feminino , Bovinos , Animais , Amido/metabolismo , Zea mays/metabolismo , Digestão , Fermentação , Lipopolissacarídeos/farmacologia , Dieta/veterinária , Lactação/fisiologia , Acidose/veterinária , Proteínas de Fase Aguda/metabolismo , Peso Corporal , Rúmen/metabolismo , Ração Animal/análise , Doenças dos Bovinos/metabolismo
2.
BJU Int ; 93(1): 71-7, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14678372

RESUMO

OBJECTIVES: To evaluate the dose-response relationship and safety/tolerability of solifenacin succinate (YM905) in the treatment of overactive bladder (OAB), and to compare its efficacy and safety/tolerability with tolterodine 2 mg twice daily. PATIENTS AND METHODS: This multicentre study included a 2-week single-blind placebo run-in, a 4-week double-blind placebo-controlled active treatment phase, and a 2-week follow-up. Men and women with an OAB and urodynamic evidence of detrusor overactivity were randomized to placebo or solifenacin 2.5, 5, 10 or 20 mg once daily, or tolterodine 2 mg twice daily. RESULTS: Of 265 patients enrolled, 225 were randomized and 192 completed the study. Solifenacin 5, 10 and 20 mg produced statistically significant (P < 0.05) improvements in voids/24 h vs placebo, whereas tolterodine did not; the mean change with tolterodine was between those with solifenacin 2.5 and 5 mg. The outcome was similar for the mean change from baseline to endpoint in mean volume voided/void. For incontinence and urgency episodes/24 h the solifenacin dose groups showed numerically superior changes vs placebo; the mean effects with tolterodine were generally smaller than with solifenacin. Most of the efficacy effect of solifenacin was evident at 2 weeks. Quality-of-life outcomes supported the efficacy results. Solifenacin 5 and 10 mg were well tolerated; there were no serious treatment-related adverse events. The incidence of dry mouth was 14% for solifenacin 5 and 10 mg, 2.6% for placebo and 24% for tolterodine. CONCLUSION: In this study, the 5- and 10-mg doses of solifenacin appeared to be the most clinically effective for treating OAB, considering the balance between efficacy, quality of life and tolerability. From the results of this study solifenacin 5 and 10 mg were selected for further evaluation in large-scale phase 3 studies.


Assuntos
Compostos Benzidrílicos/administração & dosagem , Cresóis/administração & dosagem , Antagonistas Muscarínicos/administração & dosagem , Fenilpropanolamina , Quinuclidinas/administração & dosagem , Tetra-Hidroisoquinolinas/administração & dosagem , Doenças da Bexiga Urinária/tratamento farmacológico , Retenção Urinária/tratamento farmacológico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Relação Dose-Resposta a Droga , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Método Simples-Cego , Succinato de Solifenacina , Tartarato de Tolterodina , Resultado do Tratamento , Micção/efeitos dos fármacos
3.
Dysphagia ; 15(3): 115-21, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10839823

RESUMO

In the past two decades, noteworthy advances have been made in measuring the physiologic outcomes of dysphagia, including measurement of duration of structure and bolus movements, stasis, and penetration-aspiration. However, there is a paucity of data on health outcomes from the patients' perspective, such as quality of life and patient satisfaction. A patient-based, dysphagia-specific outcomes tool is needed to enhance information on treatment variations and treatment effectiveness. We present the conceptual foundation and item generation process for the SWAL-QOL, a quality of life and quality of care outcomes tool under development for dysphagia researchers and clinicians.


Assuntos
Transtornos de Deglutição , Orofaringe/fisiopatologia , Avaliação de Resultados em Cuidados de Saúde , Qualidade de Vida , Inquéritos e Questionários , Idoso , Idoso de 80 Anos ou mais , Transtornos de Deglutição/diagnóstico , Transtornos de Deglutição/fisiopatologia , Transtornos de Deglutição/terapia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Satisfação do Paciente , Qualidade da Assistência à Saúde , Sensibilidade e Especificidade , Resultado do Tratamento
4.
Dysphagia ; 15(3): 122-33, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10839824

RESUMO

The SWAL-QOL outcomes tool was constructed for use in clinical research for patients with oropharyngeal dysphagia. The SWAL-QOL was constructed a priori to enable preliminary psychometric analyses of items and scales before its final validation. This article describes data analysis from a pretest of the SWAL-QOL. We evaluated the different domains of the SWAL-QOL for respondent burden, data quality, item variability, item convergent validity, internal consistency reliability as measured by Cronbach's alpha, and range and skewness of scale scores upon aggregation and floor and ceiling effects. The item reduction techniques outlined reduced the SWAL-QOL from 185 to 93 items. The pretest of the SWAL-QOL afforded us the opportunity to select items for the ongoing validation study which optimally met our a priori psychometric criteria of high data quality, normal item distributions, and robust evidence of item convergent validity.


Assuntos
Transtornos de Deglutição , Orofaringe/fisiopatologia , Inquéritos e Questionários , Idoso , Idoso de 80 Anos ou mais , Efeitos Psicossociais da Doença , Transtornos de Deglutição/diagnóstico , Transtornos de Deglutição/fisiopatologia , Transtornos de Deglutição/terapia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Satisfação do Paciente , Psicometria/estatística & dados numéricos , Qualidade de Vida , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
5.
World J Urol ; 13(1): 59-64, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7539680

RESUMO

The present discussion on the natural history, growth rate pathophysiology, morbidity, and possible treatment of benign prostatic hyperplasia (BPH) reinforces the need to objectify mechanical BPH-induced obstruction with pressure-flow study. Different methods for the quantification of BPH-induced obstruction exist and the grade of simplification depends on their working mechanism. To review the limitations of the current concepts, 118 BPH patients were selected for computerized pressure-flow data analysis according to quadratic passive urethral resistance relation (PURR) function. The CHESS classification differs from all other concepts due to its two-dimensional character and was developed as a result of the following way of thinking: (1) the whole individual pressure-flow plot is the most accurate basis for further analysis; (2) PURR as the true low-pressure flank of the individual plot is the most favorable definition for mechanical obstruction; (3) PURR quantification requires at least two parameters, footpoint and curvature/slope, with regard to the documented missing significant correlation of both; and (4) a two-parameter-based classification is two-dimensional (CHESS classification).


Assuntos
Obstrução do Colo da Bexiga Urinária/classificação , Idoso , Humanos , Masculino , Hiperplasia Prostática/complicações , Hiperplasia Prostática/fisiopatologia , Hiperplasia Prostática/terapia , Obstrução do Colo da Bexiga Urinária/etiologia , Urodinâmica/fisiologia
6.
Urol Int ; 47 Suppl 1: 48-51, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1949377

RESUMO

This paper describes methods of entering data into an expert system used to study lower urinary tract pressure and flow. Data is usually entered into an expert system directly from the keyboard or on an online basis. We have developed a new method of offline data entry using a photoscanner. For this method, we developed versatile software to convert the graphic data read by a photoscanner to online data format. This software allows us to handle graphic data printed on paper in the same way as online data. The software is also designed to solve the problems caused by blurred lines or ink spots on printed charts. In other words, the software compensates for data reading errors caused by blurred or stained lines on printed charts. Because data can be entered through the photoscanner, the enormous volume of data already recorded in graphic forms can be used by the expert system. As a result, the diagnostic capability of the expert system is significantly improved.


Assuntos
Diagnóstico por Computador , Sistemas Inteligentes , Urodinâmica , Processamento Eletrônico de Dados , Humanos , Software
7.
Urol Int ; 47 Suppl 1: 9-15, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1949388

RESUMO

The use of computers in urodynamics must be based preferably on the structure of the urodynamic investigation itself. This enables implementation of computerized systems in the urodynamic laboratory in the most natural way and provides transparency of urodynamic software for the investigators. Additionally, the algorithms of the urodynamic software then can provide for a urodynamic investigation following a logical path based on the patient's history and clinical data and (automatically interpreted) results from earlier steps in the urodynamics. As an extension of this structured logical reasoning, the computer use in urodynamics can be extended to include validation and decision rules, comprising measurement data and rules for interpretation and combination of history, clinical and measurement data. Conclusions will be presented then in the form of a preliminary differential diagnosis, including the odds for each of the possible diagnoses. These kinds of computerized interpretation systems will be validated by comparison with the classical clinical diagnoses and are generally known as expert systems. These systems rely on logical branching-as opposed to systems that are statistical in nature and use large data bases to classify individual data into known groups. Data bases will remain for the purpose of documentation, based on individual patients and comprising all patient data-comparable to the existing patient files in the hospital's archives. The computer files have to include also the original data from functional studies like urodynamics-and not just the abstracted conclusions-and from imaging techniques. Intelligent compression of data prevents the data bases from exploding. Digital imaging techniques combined with computerized urodynamic investigations open possibilities for dynamic analysis of morphologic data and combination thereof with urodynamic measurement data.


Assuntos
Bases de Dados Factuais , Diagnóstico por Computador , Sistemas Inteligentes , Intensificação de Imagem Radiográfica , Urodinâmica , Humanos
8.
Br J Urol ; 63(2): 176-9, 1989 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2495144

RESUMO

A total of 70 patients were treated with intravesical instillations of Mitomycin-C (MMC) following transurethral resection for superficial bladder carcinoma. In this randomised prospective study the influence of 2 exposure times (0.5 and 1 h) was studied in relation to tumour recurrence, recurrence interval, tumour progression and toxicity. The number of patients with recurrent tumours was significantly lower in the 1-h group. Tumour progression was seen in only 2 patients in each group and all had primary or secondary carcinoma in situ of the bladder or prostatic urethra. Fourteen patients were excluded from further evaluation because of side effects. A longer instillation time over a longer period and a lower dose of MMC are recommended.


Assuntos
Carcinoma in Situ/tratamento farmacológico , Carcinoma de Células de Transição/tratamento farmacológico , Mitomicinas/administração & dosagem , Recidiva Local de Neoplasia/prevenção & controle , Neoplasias da Bexiga Urinária/tratamento farmacológico , Administração Intravesical , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma in Situ/patologia , Carcinoma de Células de Transição/patologia , Ensaios Clínicos como Assunto , Esquema de Medicação , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Mitomicina , Mitomicinas/uso terapêutico , Estadiamento de Neoplasias , Estudos Prospectivos , Distribuição Aleatória , Neoplasias da Bexiga Urinária/patologia
15.
Br J Urol ; 52(3): 196-203, 1980 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7426980

RESUMO

Voidings from 7 healthy men were recorded by means of the urinary drop spectrometer. The voiding patterns were characterised by the trend drop frequency and the distribution of drop time intervals. The variability of these voiding patterns was studied by statistical techniques. The data were grouped for each person. Variances were considerable both within and between groups. Although individual differences in the mean values existed, the groups could not be separated from each other.


Assuntos
Micção , Adulto , Análise de Variância , Humanos , Masculino , Fotometria/instrumentação , Probabilidade , Fatores de Tempo , Urodinâmica , Urologia/instrumentação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...